Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Filings indexed 931 across all filing types
Latest filing 2020-08-21 Report Publication Anno…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
第十届董事会第八次会议决议公告
Report Publication Announcement Classification · 95% confidence The document is a board meeting resolution announcement from Mayinglong Pharmaceutical Group Co., Ltd. It reports the approval of the 2020 semi-annual report and its summary, and mentions that the detailed report is published on the Shanghai Stock Exchange website. The document itself does not contain the actual semi-annual financial report or substantive financial data, but rather announces the board's approval and directs readers to the full report elsewhere. The document length is short (705 characters), consistent with an announcement rather than a full report. Therefore, this is a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR).
2020-08-21 Chinese
财务管理制度(2020年8月修订)
Governance Information Classification · 95% confidence The document is titled '财务管理制度' (Financial Management System) and contains detailed internal policies and procedures related to financial management, accounting principles, budgeting, asset management, and internal controls of the company. It is a comprehensive internal financial management manual or policy document rather than a financial report, audit report, or regulatory filing. It does not contain financial statements, audit opinions, earnings data, or shareholder meeting information. It is not an announcement or a presentation but a detailed internal governance document about financial management practices. Therefore, the most appropriate classification is Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices, including financial management systems.
2020-08-21 Chinese
2020年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2020 年半年度报告摘要" which translates to "2020 Semi-Annual Report Summary." It contains detailed financial data for the first half of 2020, including assets, liabilities, income, cash flows, and shareholder information. The text discusses operating results, financial position, investment analysis, and changes in accounting policies, all typical of an interim or quarterly financial report. The document length is about 15,000 characters, indicating it is a substantive report rather than a brief announcement. There is no indication that this is an annual report (10-K) or a full year report, but rather a half-year report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-08-21 Chinese
2020年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2020 年半年度报告' which translates to '2020 Semi-Annual Report'. It covers the period from January 1, 2020 to June 30, 2020, indicating it is a report for a period shorter than a full fiscal year. The content includes detailed financial data such as revenue, profit, cash flow, asset and liability analysis, and business overview. It also contains management discussion and analysis of operating conditions, business segments, and risk factors. The document length is substantial (15,000 characters), and it contains actual financial statements and substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-08-21 Chinese
2019年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an announcement regarding the implementation of the 2019 annual equity distribution (dividend payment) by the company 马应龙药业集团股份有限公司. It details the dividend per share, relevant dates for record, ex-dividend, and payment, the approval of the distribution plan at the 2019 annual shareholders meeting, and tax withholding information. The document is relatively short (2353 characters) and focuses on dividend distribution details rather than presenting financial statements or comprehensive financial performance. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2020-07-22 Chinese
关于股价异常波动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations of the company 马应龙药业集团股份有限公司. It details the dates of the price changes, confirms no undisclosed material information exists, and provides a risk warning to investors. There is no financial data, no report attached or referenced as being published, and no mention of a formal report filing. The content fits the category of a regulatory announcement about stock price behavior and company disclosures, which aligns with Regulatory Filings (RNS). The document length is short (1077 characters), and it is clearly an announcement rather than a full report or financial statement.
2020-06-29 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.